MedTrace Logo

Zinc Supplementation and Infections in Older Medical Patients

NCT07367412 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8000

Last updated 2026-05-29

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the effect of zinc supplementation once daily for 12 months in older acute medical patients. The main question it aims to answer is:

• Can daily zinc supplementation for 12 months increase Days Alive and Out of Hospital (DAOH)? Researchers will compare zinc supplementation to a control group, a group who do not receive zinc supplementation, to see if zinc supplementation can increase Days Alive and Out of Hospital, reduce antibiotic use, readmissions and mortality.

Participants will take 22 mg zinc supplementation once daily for 12 months or not.

The researchers will draw data on readmissions, antibiotic use and mortality during the 12 months follow-up period.

Conditions

  • Older Adults (65 Years and Older)
  • Medical Patients in the Emergency Department

Interventions

DIETARY_SUPPLEMENT

Zinc (zinc sulphate)

22 mg zinc sulphate tablets taken once daily for 12 months

Sponsors & Collaborators

  • Independent Research Fund Denmark

    collaborator INDUSTRY

  • The Novo Nordic Foundation

    collaborator OTHER

  • Herlev Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2028-03-15
Completion
2028-03-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07367412 on ClinicalTrials.gov